Preface: Chromosomal instability and breast cancer pathogenesis

Journal of Mammary Gland Biology and Neoplasia

Volumn 9, Issue 3, 2004, Pages 217-220

  Venkitaraman, Ashok R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESEARCH; CANCER SUSCEPTIBILITY; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME NUMBER; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; EDITORIAL; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MALIGNANT TRANSFORMATION; TELOMERE; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; DNA DAMAGE; DNA REPAIR; FEMALE; HUMANS; RESEARCH;

EID: 9144242964     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000048769.24125.64     Document Type: Editorial

References (17)

1. N. Rahman and M. R. Stratton (1998). The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32:95-121.
2. K. N. Nathanson, R. Wooster, and B. L. Weber (2001). Breast cancer genetics: What we know and what we need. Nat. Med. 7(5):552 556.
3. R. Scully and D. M. Livingston (2000). In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408(6811):429-432.
4. A. R. Venkitaraman (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108(2):171-182.
5. H. Meijers-Heijboer, A. van den Ouweland, J. Klijn, M. Wasielewski, A. de Snoo, R. Oldenburg, A. Hollestelle, M. Houben, E. Cropin, M. van Veghel-Plandsoen, F. Elstrodt, C. van Duijn, C. Bartels, C. Meijers, M. Schulte, L. McGuffog, D. Thompson, D. Easton, N. Sodha, S. Seal, R. Barfoot, J. Mangion, D. Eccles, R. Eeles, D. G. Evans, R. Houlston, V. Murday, S. Narod, T. Peretz, J. Peto, C. Phelan, H. X. Zhang, C. Szabo, P. Devilee, D. Goldgar, P. A. Futreal, K. L. Nathanson, B. Weber, N. Rahman, and M. R. Stratton, (2002). Low-penetrance susceptibility to breast cancer due to CHEK2(*) 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31(1):55-59.
6. D. W. Bell, J. M. Varley, T. E. Szydlo, D. H. Kang, D. C. Wahrer, K. E. Shannon, N. Lubratovich, S. J. Verselis, K. J. Isselbacher, J. F. Fraumeni, J. M. Birch, F. P. Li, J. E. Garther, and D. A. Haber. (1999). Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286(5449):2528-2531.
7. D. F. Easton (1999). How many more breast cancer predisposition genes are there? Breast Cancer Res. 1(1):14-17.
8. E. C. Friedberg, G. C. Walker, and W. Siede (1995). DNA Repair and Mutagenesis. ASM Press, Washington, D.C.
9. M. M. Cox, M. F. Goodman, K. N. Kreuzer, D. J. Sherratt, S. J. Sandler, and K. J. Marians (2000). The importance of repairing stalled replication forks. Nature 404(6773):37-41.
10. T. R. Cech (2004). Beginning to understand the end of the chromosome. Cell 116(2):273 279.
11. S. Shreeram and J. J. Blow. The role of the replication licensing system in cell proliferation and cancer. Prog. Cell Cycle Res. 5:287-293.
12. J. Pines and C. L. Rieder (2001). Restaging mitosis: A contemporary view of mitotic progression. Nat. Cell Biol. 3(1):E3-E6.
13. E. A. Nigg (2002). Centrosome aberrations: Cause or consequence of cancer progression? Nat. Rev. Cancer 2(11):815-825.
14. A. L. Jackson and L. A. Loeb (1998). On the origin of multiple mutations in human cancers. Semin Cancer Biol. 8(6):421-429.
15. L. A. Loeb, K. R. Loeb, and J. P. Anderson (2003). Multiple mutations and cancer. Proc. Natl. Acad. Sci. U.S.A. 100(3):776-781.
16. B. A. J. Ponder and W. K. Cavanee (1995). Genetics and Cancer: A Second Look. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
17. J. Brugarolas and T. Jacks (1997). Double indemnity: P53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair [news]. Nat. Med. 3(7):721-722.